NDC 0074-0282 – Decnupaz

Pivekimab Sunirine 2 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC0074-0282

Product details

Brand name
Decnupaz
Generic name
Pivekimab sunirine-pvzy
Labeler
AbbVie Inc.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
BLA · BLA761460
Marketed since
May 27, 2026
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Decnupaz →

Package NDC codes (1)

Package NDCDescriptionSince
0074-0282-021 VIAL, SINGLE-DOSE in 1 CARTON (0074-0282-02) / 1.15 mL in 1 VIAL, SINGLE-DOSEMay 27, 2026